Clinical trials
Phase 3 Coronary Disease trials in Brazil
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 2 |
| 2015 | 1 |
| 2019 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 2 |
| Amgen | 1 |
| AstraZeneca | 1 |
| Conor Medsystems | 1 |
| Hoffmann-La Roche | 1 |
| Johns Hopkins University | 1 |
| University of Sao Paulo | 1 |
| University of Sao Paulo General Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Coronary Disease | 9 |
| Atherosclerosis | 3 |
| Heart Diseases | 3 |
| Cardiovascular Diseases | 2 |
| Acute Coronary Syndrome | 1 |
| Arterial Occlusive Diseases | 1 |
| Arteriosclerosis | 1 |
| Cardiac Output, Low | 1 |
| Coronary Artery Disease | 1 |
| Hypercholesterolemia | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.